术中万古霉素浸泡移植物降低前交叉韧带重建术后感染:1640例回顾性分析
该单中心回顾性研究纳入2009年5月至2018年8月间1640例前交叉韧带重建病例,比较术中万古霉素浸泡移植物与未浸泡者的术后感染率。结果显示万古霉素浸泡组感染率为0.1%(798例中1例),未浸泡组为1.2%(842例中10例)(p=0.032),相对风险降低89.4%。BMI升高、手术时间延长及未使用万古霉素浸泡移植物为术后感染的独立预测因素。
要点
- 万古霉素浸泡移植物组感染率0.1%(1/798),未浸泡组1.2%(10/842)(p=0.032)。
- 使用万古霉素浸泡移植物相对风险降低89.4%。
- BMI升高(p=0.029)、手术时间延长(p=0.001)、未使用万古霉素浸泡(p=0.032)为感染的独立预测因素。
核心结论
- 万古霉素浸泡移植物与前交叉韧带重建术后感染率降低相关(0.1% vs 1.2%;p=0.032),相对风险降低89.4%。
- BMI升高、手术时间延长及未使用万古霉素浸泡移植物为术后感染的独立预测因素。
研究设计与样本
- 单中心回顾性研究,纳入2009年5月至2018年8月间所有前交叉韧带重建病例,共1640例(男性952例,占58.0%),平均年龄27.7±11.4岁;其中初次重建1379例(84.1%)。
- 排除标准包括随访不足90天、术中使用万古霉素以外的抗生素准备移植物、同侧膝关节既往感染。
- 感染定义为术后90天内因冲洗和清创返回手术室。
- 采用t检验和Poisson回归进行统计描述与推断,显著性定义为p<0.05。
- 证据等级为治疗性III级。
主要发现
- 总计11例重建(0.7%)发生感染,其中未浸泡万古霉素组10例(1.2%),浸泡组1例(0.1%)(p=0.032)。
- 使用术中万古霉素的相对风险降低为89.4%。
- 年龄(p=0.571)、性别(p=0.707)、吸烟(p=0.407)、外科医生(p=0.124)、保险类型(p=0.616)与术后感染风险无关。
- 自体移植物使用与感染减少相关(p=0.045)。
- BMI升高(p=0.029)、手术时间延长(p=0.001)、未使用万古霉素准备移植物(p=0.032)独立预测术后感染。
关键数值与推荐
- 万古霉素浸泡组感染率0.1%(1/798) vs 未浸泡组1.2%(10/842),p=0.032。
- 相对风险降低89.4%。
- 感染独立预测因素:BMI升高(p=0.029)、手术时间延长(p=0.001)、未使用万古霉素准备移植物(p=0.032)。
- 自体移植物使用与感染减少相关(p=0.045)。
临床怎么用
- 术中采用万古霉素浸泡移植物可能与前交叉韧带重建术后感染率降低相关。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reported infection rates following anterior cruciate ligament (ACL) reconstruction are low, but infections are associated with high morbidity including reoperations and inferior clinical outcomes. The purpose of the current study was to investigate the rate of infection after ACL reconstruction with and without graft preparation with a vancomycin irrigant. METHODS: All ACL reconstructions performed between May 2009 and August 2018 at a single academic institution were reviewed and categorized based on vancomycin use. Patients with <90-day follow-up, intraoperative graft preparation with an antibiotic other than vancomycin, or previous ipsilateral knee infection were excluded. Infection was defined as a return to the operating room for irrigation and debridement within 90 days after ACL reconstruction. Descriptive and inferential statistical analysis using t tests and Poisson regression were performed, with significance defined as p < 0.05. RESULTS: In total, 1,640 patients (952 males; 58.0%) with a mean age (and standard deviation) of 27.7 ± 11.4 years underwent ACL reconstruction (1,379 primary procedures; 84.1%) and were included for analysis. Intraoperative vancomycin was used in 798 cases (48.7%), whereas 842 ACL reconstructions (51.3%) were performed without intraoperative vancomycin. In total, 11 reconstructions (0.7%) were followed by infection, which occurred in 10 (1.2%) of the patients in whom the graft was not soaked in vancomycin and in 1 (0.1%) of the patients in whom the graft was soaked in vancomycin (p = 0.032). Age (p = 0.571), sex (p = 0.707), smoking (p = 0.407), surgeon (p = 0.124), and insurance type (p = 0.616) were not associated with postoperative infection risk. Autograft use was associated with decreased infections (p = 0.045). There was an 89.4% relative risk reduction with the use of intraoperative vancomycin. An increased body mass index (BMI) (p = 0.029), increased operative time (p = 0.001), and the absence of ACL graft preparation with vancomycin (p = 0.032) independently predicted postoperative infection. CONCLUSIONS: The use of vancomycin-soaked grafts was associated with a 10-fold reduction in infection after ACL reconstruction (0.1% versus 1.2%; p = 0.032). Other risk factors for infection after ACL reconstruction included increased BMI and increased operative time. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Baron JE, Shamrock AG, Cates WT, et al. Graft Preparation with Intraoperative Vancomycin Decreases Infection After ACL Reconstruction: A Review of 1,640 Cases. J Bone Joint Surg Am. 2019. PMID: 31609893. doi:10.2106/JBJS.19.00270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。